SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001628280-22-030946
Filing Date
2022-11-29
Accepted
2022-11-29 16:11:12
Documents
1
Period of Report
2022-11-25

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_166975625707899.html 4  
1 FORM 4 wf-form4_166975625707899.xml 4 3051
  Complete submission text file 0001628280-22-030946.txt   4703
Mailing Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121
Business Address 11055 FLINTKOTE AVENUE SAN DIEGO CA 92121 858-952-7570
Cardiff Oncology, Inc. (Issuer) CIK: 0001213037 (see all company filings)

IRS No.: 272004382 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O TROVAGENE, INC. 11055 FLINTKOTE AVENUE, SUITE A SAN DIEGO CA 92121
Business Address
Erlander Mark (Reporting) CIK: 0001651537 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-35558 | Film No.: 221432900